Tigis

×

Varování

JUser: :_load: Nelze nahrát uživatele s ID: 64
2013
pátek, 30 listopad 2001 00:00

Psychiatrie 4/2013

Editorial.........................................................................................................................168

Přehledné články
Petr Winkler, Ladislav Csémy
Systémy psychiatrické péče v Evropě II: komparace jednotlivých komponent...................... 172

Aleš Kolářský
Motivační paradigma I: Myšlenkové předpoklady Ke stému výročí narození Kurta Freunda ... 177

Vzdělávání
Klára Látalová, Dana Kamarádová, Ján Praško
Komplikované truchlení a jeho léčba  .............................................................................. 181

Fórum české neuropsychofarmakologické společnosti
Pavel Mohr, Martin Anders, Radovan Přikryl, Jiří Masopust, Ján Praško, Cyril Höschl
Konsensus ČNPS o diagnostice a léčbě ADHD v dospělosti ..............................................189

Zprávy .......................................................................................................................... 203
Přečetli jsme za vás ...................................................................................................... 214
Nové knihy .................................................................................................................... 216
Informace ...................................................................................................................... 217
rejstříky 2013................................................................................................................. 218

CONTENTS

Editorial.........................................................................................................................168

Reviews
Petr Winkler, Ladislav Csémy
Psychiatric care systems across Europe II: comparison of single components ....................172

Aleš Kolářský
Motivational paradigm I: conceptual background (To 100 anniversary of Kurt Freund) .............177

CME
Klára Látalová, Dana Kamarádová, Ján Praško
Complicated grief and its treatment ..................................................................................181

Forum of the Czech Neuropsychopharmacological Society
Pavel Mohr, Martin Anders, Radovan Přikryl, Jiří Masopust, Ján Praško, Cyril Höschl
Consensus of the Czech Neuropsychopharmacological Society
on the diagnosis and treatment of adult ADHD...................................................................189

News ............................................................................................................................ 203
We have read for you ...................................................................................................... 214
New Books .................................................................................................................... 216
Information ..................................................................................................................... 217
Index 2013.......................................................................................................................218

pondělí, 30 listopad -0001 00:00

Psychiatrie 3/2013

OBSAH

Editorial......................................................................................................................109

Původní práce
Radka Bužgová, Erika Hajnová, David Feltl
Výskyt úzkosti a deprese u pacientů v paliativní
péči při hospitalizacina onkologickém oddělení: pilotní studie...........................................117

Lucie Bankovská Motlová, Eva Dragomirecká, Anna Blabolová, Filip Španiel,
Andrea Slováková, Petr Pokorný
Psychoedukace u schizofrenie očima pacientů.
Průzkum názorů pacientů na psychoedukaci v České republice v roce 2009.....................122

Přehledné články
Anna Pivovarčiová, Boris Mravec
Psychické poruchy a neurologické choroby: význam nervus vagus.................................. 129

Zdeňka Navrátilová, Jiří Patočka
Withania somnifera – indický ženšen.............................................................................141

Vzdělávání
Richard Köhler
Delirium na somatických odděleních.............................................................................145

Fórum české neuropsychofarmakologické společnosti
Alexandra Šulcová, Petr Popov
Nalmefen v léčbě alkoholové závislosti...........................................................................151

Zprávy.........................................................................................................................156

Přečetli jsme za vás.....................................................................................................159

Dopisy, ohlasy, diskuze................................................................................................161

Nové knihy...................................................................................................................164

CONTENTS

Editorial.......................................................................................................................109

Original papers
Radka Bužgová, Erika Hajnová, David Feltl
The Incidence of Anxiety and Depression in Patients in Palliative
Care during their hospitalization at oncology clinic: a pilot study.......................................117

Lucie Bankovská Motlová, Eva Dragomirecká, Anna Blabolová, Filip Španiel,
Andrea Slováková, Petr Pokorný
Psychoeducation in schizophrenia: patients’ view. patients’ opinion
survey on psychoeducation in the Czech Republic in 2009..............................................122

Reviews
Anna Pivovarčiová, Boris Mravec
Psychiatric disorders and neurological diseases: the role of the vagus nerve.....................129

Zdeňka Navrátilová, Jiří Patočka
Withania somnifera – indian ginseng.............................................................................141

CME
Richard Köhler
Delirium at somatic departments..................................................................................145

Forum of the czech neuropsychopharmacological society
Alexandra Šulcová, Petr Popov
Nalmefene in treatment of alcohol dependence..............................................................151

News.........................................................................................................................156

We have read for you..................................................................................................159

Letters, response, discussion......................................................................................161

New Books................................................................................................................164

středa, 26 červen 2013 12:39

Psychiatrie 2/2013

EDITORIAL ............................................................................................ 56

Původní práce
Marek Preiss, Galina Mačudová
Dotazník žádoucího stylu odpovídání (BIDR-CZ) ......................................... 59

Přehledné články
Petr Winkler, Miroslava Janoušková
Systémy psychiatrické péče v Evropě I:
popis reformních procesů ve 12 zemích EU .............................................. 65

Jiří Patočka, Ondřej Soukup, Kamil Kuča
Ladostigil – další snaha o dualistické kognitivum ....................................... 71

Michal Patarák
Systém odmeny, dopamín a ich úloha v predikčnom učení........................... 74

Miroslav Turjap, Jan Juřica
Terapeutické monitorování klozapinu a olanzapinu....................................... 80

Vzdělávání
Jan Bažant
Metakognitivní terapie (MCT)..................................................................... 86

Fórum České NeuroPsychofarmakologické Společnosti
Ladislav Hosák, Jaroslav Pokorný, Jindřich Mourek, Omar Šerý
Epigenetika a nekódující RNA ve vztahu k psychofarmakoterapii ..................93

Zprávy ...................................................................................................100
Přečetli jsme za vás ...............................................................................106
Nové knihy..............................................................................................107

CONTENTS

EDITORIAL .............................................................................................. 56
Original papers
Marek Preiss, Galina Mačudová
Czech version of Balanced Inventory of Desirable Responding (BIDR-CZ) ........ 59

Reviews
Petr Winkler, Miroslava Janoušková
Psychiatric care systems across Europe I:
description of reform processes in 12 EU countries ....................................... 65

Jiří Patočka, Ondřej Soukup, Kamil Kuča
Ladostigil – another pursuit of a dual action cognitive enhancer ...................... 71

Michal Patarák
Reward system, dopamine and their role in predictive learning......................... 74

Miroslav Turjap, Jan Juřica
Therapeutic drug monitoring of clozapine and olanzapine................................ 80

CME
Jan Bažant
Metacognitive Therapy (MCT) ...................................................................... 86

Forum of the Czech NeuroPsychopharmacological Society
Ladislav Hosák, Jaroslav Pokorný, Jindřich Mourek, Omar Šerý
Epigenetics and non-coding rna in a relationship to psychopharmacotherapy ..... 93

News ...........................................................................................................100
We have read for you ....................................................................................106
New Books ...................................................................................................107

úterý, 11 červen 2013 08:31

Psychiatrie Suppl. 2/2013

Editorial .................................................................................................................................... 1

Medailonek ............................................................................................................................... 4

Program ....................................................................................................................................5

Abstrakta .................................................................................................................................10

Postery .....................................................................................................................................58

Rejstřík autorů .........................................................................................................................103

CONTENTS

Editorial ..................................................................................................................................... 1

Cameo .......................................................................................................................................4

Programme .................................................................................................................................5

Abstracts ..................................................................................................................................10

Postery .....................................................................................................................................58

Index of authors ........................................................................................................................103

čtvrtek, 28 březen 2013 10:29

Psychiatrie 1/2013

Editorial .......................................................................................................................................1
Původní práce
Miloslav Kopeček, Klára Látalová, Dagmar Dvořáková, Simona Papežová,
Markéta Zemanová, Jan Tuček, Pavel Mohr
Stručný kognitivní test (SCOT): skríninkový nástroj k měření kognitivního postižení u pacientů
se schizofrenií a bipolární afektivní poruchou (pilotní data)..................................................................... 5

Přehledné články
Ľubomíra Izáková, Daniela Ježová
Aldosterón – nový biologický marker alebo ďalšia možnost v liečbe depresie? .......................................13

Anna Kubešová, Jiří Horáček
Vliv psychotropních látek na neurogenezi v dospělém savčím hipokampu .............................................19

Aleš Bartoš, Pavel Martínek, Daniela Řípová
Hodnocení soběstačnosti u pacientů s mírnou kognitivní poruchou a demencí .......................................23

Vzdělávání
Pavel Theiner, Tomáš Kašpárek, Alena Fiľová
Hyperkinetická porucha (ADHD) .......................................................................................................27

Fórum české neuropsychofarmakologické společnosti
Martin Anders, Jakub Albrecht
Nové antidepresivum s multimodálním mechanizmem účinku – vortioxetin (Lu-AA21004) ......................35

Zprávy ...........................................................................................................................................43
Přečetli jsme za vás .......................................................................................................................48
Dopisy, ohlasy, diskuze ..................................................................................................................50
Nové knihy ....................................................................................................................................52

CONTENTS

Editorial.......................................................................................................................................... 1

Original papers
Miloslav Kopeček, Klára Látalová, Dagmar Dvořáková, Simona Papežová,
Markéta Zemanová, Jan Tuček, Pavel Mohr
Short Cognitive Test (Scot): A screening instrument to measure cognitive impairment in patients
with schizophrenia and bipolar disorder (A pilot study) ......................................................................... 5

Reviews
Ľubomíra Izáková, Daniela Ježová
Aldosterone – a new biological marker or another option in the treatment of depression? .......................13

Anna Kubešová, Jiří Horáček
The influence of psychotropic drugs on neurogenesis in the adult mammalian hippocampus ..................19

Aleš Bartoš, Pavel Martínek, Daniela Řípová
Evaluation of activities of daily living in patients with cognitive disorders ...............................................23

CME
Pavel Theiner, Tomáš Kašpárek, Alena Fiľová
Hyperkinetic disorder (Adhd) ........................................................................................................... 27

Forum of the Czech Neuropsychopharmacological Society
Martin Anders, Jakub Albrecht
A novel multimodal antidepressant compound – vortioxetine (Lu-AA21004) ..........................................35

News ............................................................................................................................................43
We have read for you ..................................................................................................................... 48
Letters, response, discussion .........................................................................................................50
New Books ................................................................................................................................... 52

úterý, 18 prosinec 2012 12:02

Psychiatrie Suppl. 1 /2013

Editorial ...............................................................................................................................1
Program ...............................................................................................................................4

Plenární přednášky
prof. Dr. Hans-Ulrich Wittchen ................................................................................................11
prof. Jan Volavka, MD, PhD. ...................................................................................................11
prof. ThDr. Otakar A. Funda, Dr. Theol......................................................................................11

Odborná sympozia
Sympozium Společnosti pro biologickou psychiatrii:
Abnormní pohyby v psychiatrii a neurologii .............................................................................12
Terapeutické implikace klinicko-patologických korelací neurodegenerativních onemocnění ..........13
Antipsychotika .....................................................................................................................14
Personalizovaná léčba psychofarmaky ...................................................................................16
Sympozium České a Slovenské psychiatrické společnosti:
Farmakoterapie psychický poruch – záleží na pohlaví? ............................................................16
EPIGENOM – nové interpretační možnosti genetiky ................................................................18
Antidepresiva ...................................................................................................................... 19
Thymoprofylaktika ................................................................................................................21
Psychofarmaka v sexuologii ..................................................................................................22
Význam endokanabinoidního sytému u psychiatrických poruch a jejich léčení........................... 23
Anxiolytika – od mechanizmu účinku k praxi.......................................................................... 24
Farmakoterapie a psychoterapie – spolu nebo zvlášť?............................................................. 26
Obsedantně kompulzivní porucha – od psychopatologie k léčbě ...............................................28
Ketamin: Léčebné a výzkumné využití v psychiatrii...................................................................29
Možnosti predikce individuálního průběhu schizofrenie .............................................................31
Personalizované přístupy v diagnostice a léčbě Alzheimerovy choroby ..................................... 32
SETKÁNÍ S ODBORNÍKEM
doc. MUDr. Eva Malá, CSc. ..................................................................................................34
prim. MUDr. Michal Maršálek, CSc. .......................................................................................34
prof. MUDr. Cyril Höschl, DrSc., FRCPsych. ......................................................................... 34
PRACOVNÍ SNÍDANĚ ČNPS
Terapeutické monitorování psychofarmak – význam pro klinickou praxi .....................................35
Nový výzkum
Nový výzkum – Preklinický výzkum .......................................................................................37
Nový výzkum – Klinický výzkum I ..........................................................................................39
Nový výzkum – Klinický výzkum II ........................................................................................ 41
Workshopy
Komplexní přístup v léčbě hraniční poruchy osobnosti..............................................................43
Sedmero hlavních hříchů – Závist ...........................................................................................44
Komplexní léčba úzkostných poruch ......................................................................................46
Diferenciální diagnostika a farmakoterapie demencí III ..............................................................48
Neuropsychiatrické omyly, alarmující příběhy z praxe ............................................................. 48
Vývěsková sdělení
Vývěsková sdělení – Preklinické studie ..................................................................................49
Vývěsková sdělení – Klinické studie....................................................................................... 55
Vývěsková sdělení – Cholinergní neurotransmise, léčba Alzheimerovy choroby ..........................64
Firemní sympozia .................................................................................................................70
Jmenný rejstřík ................................................................................................................... 71

CONTENTS

Editorial................................................................................................................................ 1
Programme............................................................................................................................4
PLENARY LECTURES
prof. Dr. Hans-Ulrich Wittchen ...............................................................................................11
prof. Jan Volavka, MD, PhD. ................................................................................................. 11
prof. ThDr. Otakar A. Funda, Dr. Theol. ...................................................................................11
SCIENTIFIC SYMPOSIA
Abnormal movements in psychiatry and neurology
(Symposium of the Society of Biological Psychiatry) ..............................................................12
Clinico-pathological correlations in neurodegenerative dementias
and their treatment implications ............................................................................................13
Antipsychotics ....................................................................................................................14
Personalized treatment with psychotropic drugs .....................................................................16
Pharmacotherapy of psychic disorders – does the gender matter?
(Sympozium of Czech and Slovak Psychiatric Society) ...........................................................16
The role of endocannabinoid system in psychiatric disorder and their treatment .........................18
EPIGENOM – new aspects for interpretation in genetics ..........................................................19
Antidepressants ...................................................................................................................21
Mood stabilizers ..................................................................................................................22
Psychotropic drugs and sexology ..........................................................................................23
Anxiolytics – from the mechanism of action to the practise ......................................................24
Pharmacotherapy and psychotherapy – together or separately .................................................26
Obsessive compulsive disorder – from psychopathology to the treatment ..................................28
Ketamine: Treatment and research use in psychiatry ..............................................................29
Prediction of individual course of schizophrenia – ways and possibilities ...................................31
Personalized approach in diagnostic and treatment of Alzheimer disease .................................32
MEET THE EXPERT
doc. MUDr. Eva Malá, CSc. ..................................................................................................34
prim. MUDr. Michal Maršálek, CSc. .......................................................................................34
prof. MUDr. Cyril Höschl, DrSc., FRCPsych. ..........................................................................34
ČNPS BREAKFAST SYMPOSIA
Therapeutic monitoring of psychotropic drugs – relevance to clinical practise ............................35
NEW RESEARCH
New research – Preclinical research .....................................................................................37
New research – Clinical research I ........................................................................................39
New research – Clinical research II ........................................................................................41
WORKSHOPS
Complex approach to the patients with borderline personality disorder ......................................43
Seven deadly sins – Envy ....................................................................................................44
Complex treatment of anxiety disorders ................................................................................46
Differencial diagnosis and pharmacotherapy of dementias ......................................................48
Neuropsychiatric mistakes – alarming stories from clinical practice......................................... 48
POSTER SESSIONS
Poster sessions – Preclinical research .................................................................................49
Poster sessions – Clinical research ......................................................................................55
Poster sessions – Cholinergic neurotransmission, treatment of Alzheimer disease .................. 64
SPONSORED SATELLITE SYMPOSIA ................................................................................70
NAME INDEX .....................................................................................................................71